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Figure 4 | 13C-Allylglycine synthesis. i) Cbz-Cl, NaOH (aq),
toluene, 0 °C  rt ; tBuOH, DCC, DMAP, CH2Cl2 ; H2 (6 bar),
Pd/C (10%wt, dry), HCl, MeOH ; Ph2C=NH, CH2Cl2, MgSO4. ii)
CH2=CH-CH2-Br, KOH (50%wt, aq), toluene, CH2Cl2, -20 °C. iii)
citric acid (10%wt, aq), THF ; Fmoc-OSu, THF, H2O (51%, 7
steps).
3. Cross-metatheses and PG removal
Protecting groups (PG) of 10 were chosen to suit
future solid phase peptide synthesis. In this case, CM
yields were very satisfying. Unfortunately the Fmoc
removal proved to be the most challenging step of
these syntheses.
Figure 5 | 13C-m-A2pm synthesis. i) Grubbs 2nd gen. cat. 10
mol%, CH2Cl2, reflux, N2 (yield = 66%). ii) HCl (2 M, aq), 1,4-
dioxane, reflux ; H2 (6 bar), Pd, HCl, MeOH (35%, 2 steps).
Figure 6 | m-A2pm and 2H2-m-A2pm syntheses. i) Grubbs 2nd
gen. cat. 20 mol%, CH2Cl2, reflux, N2 (yield = 35%). ii) HCl
(2 M, aq), 1,4-dioxane, reflux ; H2 (6 bar), Pd, MeOH, H2O
(95%, 2 steps). iii) HCl (2N, aq), 1,4-dioxane, reflux ; 2H2 (6
bar), Pd, MeOH, H2O (95%, 2 steps).
Due to heavy use of antibiotics in our modern society,
bacteria developed many resistance mechanisms. It is
only a matter of time before the latest discovered
antibiotic becomes obsolete[1,2,3]. In that regard
scientists continuously need to find new targets to
design new antibiotics.
meso-2,6-Diaminopimelic acid or m-A2pm, is a diamino
diacid only found in bacterial peptidoglycan. It is
essential to a large proportion of bacterial species,
mostly Gram negative bacteria, allowing reticulation
between glycan strands (Figure 1).
Bacteria can not survive without peptidoglycan. This
macromolecule has a structural role and allows them to
resist to their high inner osmotic pressure. Therefore
peptidoglycan metabolism is a target of choice in
antibiotics development.
In this work, we synthesized stable isotopomers (13C1
and 2H2) of m-A2pm to provide tools that will help
biologists to study peptidoglycan metabolism.
1. Strategy
The key intermediate of our strategy is pictured in
Figure 2. This family of compounds can be obtained by
cross metathesis (CM) between vinylglycine (Vgl) and
allylglycine (Agl) synthons[4].
Figure 2 | Key intermediate.
Deuterium can be introduced in the synthesis after the
CM step by catalytic reduction of the alkene bond. The
cheapest way to introduce carbon-13 is to synthesize a
13C-Agl from glycine-1-13C (154€/g).
2. Allylglycine synthons synthesis
(S)-Allylglycine synthons 4a and 4b were prepared by
alkylation of N-(diphenylmethylene)glycine tert-butyl
ester 1 (a Schiff base, commercially available) using
chiral phase transfer catalysis (Figure 3). The
cinchonidine based catalyst 2 was synthesized in our
lab[5].
Figure 3 | 12C-Allylglycines syntheses. i) CH2=CH-CH2-Br,
KOH (50%wt, aq), toluene, CH2Cl2, -20°C. ii) citric acid (10%wt,
aq), THF ; 4a : Fmoc-OSu, THF, H2O (67%, 3 steps) ; 4b : Cbz-
Cl, Na2CO3 (10%wt, aq), toluene, 0 °C (53%, 3 steps).
Enantiomeric excess are very satisfying (4a 97% ee,
4b 90% ee, measured on chiral Daicel OD-H HPLC
column). Once 13C-Schiff base 6 prepared from
glycine-1-13C 5 (Figure 4), the same alkylation process
was applied to yield protected 13C-Agl 8. Vinylglycine
synthon 9 (Figure 5) was also synthesized in our lab[6]
(65%, 3 steps, ee = 98%).
To avoid difficult PG removal, we specifically
synthesized CM product 12 which can easily lead to 13
and 14. A simple HCl-dioxane treatment of 12 allowed
the esters cleavage. Then choice of H2 or
2H2 in the
last catalytic reduction step permitted production of m-




All molecules were analyzed in mass spectrometry, 1H
and 13C NMR. Some evidences of labelling are
pictured in the following spectra (Figure 7).
Figure 7 | First column : ESI-MS spectra [M+H+]. Second
column : 1H NMR. Bottom : 13C NMR spectrum of 13C-m-A2pm.
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Figure 1 | Peptidoglycan structure from Escherichia coli, 
m-A2pm highlighted in red.
In this study, we prepared 3 different isotopomers of m-A2pm by cross metathesis : natural m-A2pm (18%, 6 steps),
2H2-m-A2pm (18%, 6 steps) and
13C-m-A2pm (12%,
10 steps). This last synthesis still needs some optimization in the last step. These compounds will be analyzed in HPLC to determine their diastereomeric excesses but no
evidence of racemization was observed in NMR and HPLC analyses. Shortly, we will use a similar strategy to produce tritiated 3H2-m-A2pm.
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